AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 55 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $36,196 | – | 21,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $42,776,000 | 100.00% |
| Latash Investments, LLC | 243,134 | $1,060,000 | 0.66% |
| Bracebridge Capital, LLC | 428,571 | $1,869,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 297,229 | $1,296,000 | 0.13% |
| PDT Partners, LLC | 76,100 | $332,000 | 0.02% |
| Jump Financial, LLC | 49,700 | $216,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $798,000 | 0.02% |
| IndexIQ Advisors LLC | 86,461 | $377,000 | 0.01% |
| Financial Advocates Investment Management | 17,000 | $74,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 125,016 | $545,000 | 0.00% |